Results 1 to 10 of about 521,540 (262)

LINC00892 Is an lncRNA Induced by T Cell Activation and Expressed by Follicular Lymphoma-Resident T Helper Cells

open access: yesNon-Coding RNA, 2022
Successful immunotherapy in both solid tumors and in hematological malignancies relies on the ability of T lymphocytes to infiltrate the cancer tissue and mount an immune response against the tumor.
Ingram Iaccarino   +8 more
doaj   +1 more source

Mutational landscape of high-grade B-cell lymphoma with MYC-, BCL2 and/or BCL6 rearrangements characterized by whole-exome sequencing

open access: yesHaematologica, 2021
High-grade B-cell lymphoma accompanied with double/triple-hit MYC and BCL2 and/or BCL6 rearrangements (HGBLDH/ TH) poses a cytogenetically-defined provisional entity among aggressive B-cell lymphomas that is traditionally associated with unfavorable ...
Axel Künstner   +14 more
doaj   +1 more source

Adoptive Cell Transfer of Allogeneic Epstein–Barr Virus-Specific T Lymphocytes for Treatment of Refractory EBV-Associated Posttransplant Smooth Muscle Tumors: A Case Report

open access: yesFrontiers in Immunology, 2021
Posttransplant smooth muscle tumors (PTSMTs) are rare Epstein–Barr virus (EBV)-associated neoplasms, mostly occurring after solid organ transplantation. Current therapeutic strategies include surgery and reduction of immunosuppressive medication.
Bjoern-Thore Hansen   +9 more
doaj   +1 more source

Antibody-Negative Paraneoplastic Autoimmune Multiorgan Syndrome (PAMS) in a Patient with Follicular Lymphoma Accompanied by an Excess of Peripheral Blood CD8+ Lymphocytes

open access: yesCurrent Oncology, 2022
Paraneoplastic autoimmune multiorgan syndrome (PAMS) is a life-threatening autoimmune disease associated with malignancies. Here, we present a patient initially misdiagnosed with “chronic” Stevens–Johnson syndrome.
Thilo Gambichler   +9 more
doaj   +1 more source

Genomic insights into the pathogenesis of Epstein–Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing

open access: yesBlood Cancer Journal, 2021
Epstein–Barr virus (EBV)-associated diffuse large B-cell lymphoma not otherwise specified (DLBCL NOS) constitute a distinct clinicopathological entity in the current World Health Organization (WHO) classification.
Niklas Gebauer   +19 more
doaj   +1 more source

A retrospective study of factors affecting contralateral central-neck lymph node metastasis in unilateral papillary thyroid carcinoma

open access: yesAsian Journal of Surgery, 2023
Background: In 30–40% of papillary thyroid cancer patients, central neck lymph node metastasis occurs. As a result, prophylactic central neck lymph node dissection is performed. The extent of lymph node dissection and prophylactic central neck lymph node
Seok Kyung Kang   +6 more
doaj   +1 more source

Quantification of minimal disseminated disease by quantitative polymerase chain reaction and digital polymerase chain reaction for NPM-ALK as a prognostic factor in children with anaplastic large cell lymphoma

open access: yesHaematologica, 2020
Detection of minimal disseminated disease is a validated prognostic factor in ALK-positive anaplastic large cell lymphoma. We previously reported that quantification of minimal disease by quantitative real-time polymerase chain reaction (RQ-PCR) in bone ...
Christine Damm-Welk   +8 more
doaj   +1 more source

Expression of CD8 is associated with non-common type morphology and outcome in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma

open access: yesHaematologica, 2013
Anaplastic lymphoma kinase-positive anaplastic large T-cell lymphoma is characterized by morphological variability. Morphological variants (non-common subtype) are associated with a poor outcome.
Dmitriy Abramov   +6 more
doaj   +1 more source

Risk factors and prediction model of level II lymph node metastasis in papillary thyroid carcinoma

open access: yesFrontiers in Oncology, 2022
IntroductionSurgical management of lateral lymph nodes in papillary thyroid carcinoma, especially at level II, remains controversial. This study aimed to investigate the risk factors for level II lymph node metastasis in patients with papillary thyroid ...
Chun Huang   +3 more
doaj   +1 more source

Risk factors for Delphian lymph node metastasis in papillary thyroid carcinoma [PDF]

open access: yesWaike lilun yu shijian, 2022
Objective To investigate the risk factors for Delphian lymph node metastasis in papillary thyroid carcinoma. Methods Retrospective analysis of 99 patients treated in Taizhou Cancer Hospital from July 2017 to July 2019 were done in this study.
YAN Haibo, XIA Zhongping, CHEN Shan, JIANG Lin, HAN Chun
doaj   +1 more source

Home - About - Disclaimer - Privacy